New type 2 diabetes treatment could help patients stop taking insulin

Credit: Unsplash+

Diabetes affects over 37 million people in the United States, with the majority grappling with type 2 diabetes.

While this condition is commonly associated with older individuals, an increasing number of young people are also receiving this diagnosis.

Typically, individuals with type 2 diabetes must take medications or even inject insulin daily to manage their blood sugar levels. But what if there was a different, simpler solution on the horizon?

A Fresh Approach: ReCET Treatment

Researchers have unveiled an innovative treatment called ReCET, short for Re-cellularization via Electroporation Therapy, which could potentially revolutionize the way we manage type 2 diabetes.

ReCET treatment involves using controlled electric pulses to alter the inner lining of the small intestine.

Doctors perform this procedure with a specialized tube known as an endoscope, which they insert through the patient’s mouth to examine the small intestine.

In a preliminary study involving 14 individuals diagnosed with type 2 diabetes, participants underwent the ReCET treatment before embarking on a special diet for a duration of two weeks.

Subsequently, they began taking a diabetes medication called semaglutide. This medication has been known to enable some individuals to discontinue insulin injections, though it may not be effective for everyone.

Why This Could Be a Game-Changer

The initial outcomes of the study are highly encouraging. Most participants were able to cease insulin injections while maintaining excellent control over their blood sugar levels.

Researchers speculate that the ReCET treatment enhances the body’s ability to use insulin efficiently, thereby reducing the need for medication.

This development could significantly improve the lives of countless individuals, liberating them from the burden of daily insulin injections. However, it is essential to emphasize that further research is necessary to ensure the safety and efficacy of ReCET.

Should these positive results persist through further investigations, the ReCET treatment could represent a significant stride forward in the management of type 2 diabetes.

Exploring Other Options

In addition to groundbreaking treatments like ReCET, it is vital to recognize the crucial role that a healthy lifestyle plays in preventing type 2 diabetes.

This includes engaging in regular physical activity, adhering to a well-balanced diet, quitting smoking, and moderating alcohol consumption.

The field of diabetes research continues to flourish, with ongoing studies examining various diets and medications that may aid in the management and prevention of the condition.

For instance, the MIND diet may reduce the risk of vision loss, and the drug metformin shows promise in slowing down mental decline.

If you or someone you know is grappling with diabetes, it is wise to stay informed about these promising developments, as they could offer new avenues for improving the quality of life for individuals with type 2 diabetes.


The presentation of the ReCET treatment at Digestive Disease Week in 2023 is a hopeful sign of what the future may hold for those dealing with type 2 diabetes.

With a potential solution on the horizon, it is essential to remember that a healthy lifestyle remains a crucial factor in diabetes prevention and management.

As research in the field of diabetes continues to evolve, there is reason to believe that more effective treatments and preventive measures will emerge, offering renewed hope to millions of individuals affected by this condition.

If you care about blood sugar, please read studies about why blood sugar is high in the morning, and how to cook sweet potatoes without increasing blood sugar.

For more information about brain health, please see recent studies about 9 unhealthy habits that damage your brain, and results showing this stuff in cannabis may protect aging brain, treat Alzheimer’s.

Follow us on Twitter for more articles about this topic.

Copyright © 2023 Knowridge Science Report. All rights reserved.